Carolyn M. Tastad - 01 Mar 2022 Form 4 Insider Report for PROCTER & GAMBLE Co (PG)

Role: CEO - Health Care
Signature: /s/ Aaron B. Shepherd, attorney-in-fact for Carolyn M. Tastad
Issuer symbol: PG
Transactions as of: 01 Mar 2022
Net transactions value: -$572,597
Form type: 4
Filing time: 03 Mar 2022, 08:54:05 UTC
Previous filing: 11 Feb 2022
Next filing: 10 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PG	Common Stock	Sale	$572,597	-3,730	-12%	$153.51	28,156	01 Mar 2022	Direct	F1, F2
holding	PG	Common Stock						5,886	01 Mar 2022	By Retirement Plan Trustee	F3
holding	PG	Common Stock						1,993	01 Mar 2022	By Spouse
holding	PG	Common Stock						668	01 Mar 2022	By Spouse, By Retirement Plan Trustees	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PG	Restricted Stock Units	Award	$0	+39	+6.3%	$0.000000	659	15 Feb 2022	Common Stock	39		Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award.
F2	Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
F3	Reflects adjustment to PST through December 31, 2021.
F4	Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
F5	These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.